Anjarium Biosciences is based in Schlieren, Switzerland. It has raised $60M in total funding. Latest round: Series A.
Anjarium Biosciences is based in Schlieren, Switzerland. Anjarium Biosciences has raised $60M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in September 2021. The round record for Anjarium Biosciences runs through 2021; nothing later has been disclosed. Investors on record include Abingworth, Gimv, Pfizer Ventures, Surveyor Capital, Omega Funds, Sofinnova Investments. 6 distinct backers are named across the disclosed rounds.
Round data for Anjarium Biosciences is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Schlieren and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026